is oral semaglutide safe ADA 2025: Demonstrates Cardiovascular Benefits in SOUL Trial A Retrospective Study Evaluating the

Track your body composition over time, not just your scale weight

NHS England rolled out tirzepatide for weight management in cohorts after NICE TA1026 in December 2024: 3 Cohort 1 (from June 2025): adults with a body mass index (BMI) of 40 or higher and at least four of five weight-related conditions (type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease)

Early detection and management can help prevent more serious complications and ensure a better overall experience with the medication

The compounded alternative is immediately accessible, legally obtained, prepared by licensed pharmacies, and contains the same active ingredient as brand-name Ozempic

Hypoglycemia risk increases in patients with type 2 diabetes, particularly those taking insulin or sulfonylureas alongside GLP-1 therapy